Nomura upgraded Raffles Medical Group to Buy from Neutral with an unchanged price target of S$1.60. The analyst sees the company benefiting from an increase in local and foreign patients in its Singapore hospitals.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>